Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.

Autor: Pizzuti L; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Krasniqi E; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Barchiesi G; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Della Giulia M; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Izzo F; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Sanguineti G; Department of Radiation Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Marchetti P; Medical Oncology Unit, Azienda Ospedaliera Universitaria Sant'Andrea, Rome, Italy.; Medical Oncology Unit B, Policlinico Umberto I, Rome, Italy., Mazzotta M; Medical Oncology Unit, Azienda Ospedaliera Universitaria Sant'Andrea, Rome, Italy., Giusti R; Medical Oncology Unit, Azienda Ospedaliera Universitaria Sant'Andrea, Rome, Italy., Botticelli A; Medical Oncology Unit B, Policlinico Umberto I, Rome, Italy., Gamucci T; Medical Oncology, Sandro Pertini Hospital, Rome, Italy., Natoli C; Department of Medical, Oral and Biotechnological Sciences, Centro Scienze dell'Invecchiamento e Medicina Traslazionale -CeSI-MeT, Chieti, Italy., Grassadonia A; Department of Medical, Oral and Biotechnological Sciences, Centro Scienze dell'Invecchiamento e Medicina Traslazionale -CeSI-MeT, Chieti, Italy., Tinari N; Department of Medical, Oral and Biotechnological Sciences, Centro Scienze dell'Invecchiamento e Medicina Traslazionale -CeSI-MeT, Chieti, Italy., Iezzi L; Department of Medical, Oral and Biotechnological Sciences, Centro Scienze dell'Invecchiamento e Medicina Traslazionale -CeSI-MeT, Chieti, Italy., Tomao S; Department of Radiological, Oncological and Anatomo-Pathological Sciences, 'Sapienza' University of Rome, Policlinico Umberto I, Rome, Italy., Tomao F; Department of Gynecology-Obstetrics and Urology, 'Sapienza' University of Rome, Rome, Italy., Tonini G; Department of Oncology, University Campus Biomedico of Rome, Rome, Italy., Santini D; Department of Oncology, University Campus Biomedico of Rome, Rome, Italy., Astone A; Division of Medical Oncology, Villa San Pietro Hospital, Rome, Italy., Michelotti A; UO Oncologia Medica I, S. Chiara Hospital, Dipartimentodi Oncologia, Dei Trapianti e Delle Nuove Tecnologie, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy., De Angelis C; UO Oncologia Medica I, S. Chiara Hospital, Dipartimentodi Oncologia, Dei Trapianti e Delle Nuove Tecnologie, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy., Mentuccia L; Medical Oncology Unit, ASL Frosinone, Frosinone, Italy., Vaccaro A; Medical Oncology Unit, ASL Frosinone, Frosinone, Italy., Magnolfi E; Medical Oncology Unit, ASL Frosinone, Frosinone, Italy., Gelibter A; Medical Oncology Unit B, Policlinico Umberto I, Rome, Italy., Magri V; Medical Oncology Unit B, Policlinico Umberto I, Rome, Italy., Cortesi E; Medical Oncology Unit B, Policlinico Umberto I, Rome, Italy., D'Onofrio L; Department of Oncology, University Campus Biomedico of Rome, Rome, Italy., Cassano A; Department of Medical Oncology, Policlinico Universitario 'A. Gemelli', Rome, Italy.; Universita Cattolica del Sacro Cuore, Roma., Rossi E; Department of Medical Oncology, Policlinico Universitario 'A. Gemelli', Rome, Italy., Cazzaniga M; Research Unit Phase I trials and Oncology Unit, ASST Monza, Monza, Italy., Moscetti L; Division of Medical Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy., Omarini C; Division of Medical Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy., Piacentini F; Division of Medical Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy., Fabbri MA; Medical Oncology Unit, Belcolle Hospital, Viterbo, Italy., Scinto AF; Medical Oncology Unit, Fatebenefratelli Hospital, Rome, Italy., Corsi D; Medical Oncology Unit, Fatebenefratelli Hospital, Rome, Italy., Carbognin L; Gynecology Oncology Unit, Catholic University of the Sacred Heart, Rome, Italy., Bria E; Department of Medical Oncology, Policlinico Universitario 'A. Gemelli', Rome, Italy.; Universita Cattolica del Sacro Cuore, Roma., La Verde N; Oncology Unit, ASST Fatebenefratelli Sacco Presidio Ospedaliero Fatebenefratelli, Milano, Italy., Samaritani R; Medical Oncology Unit, 'Regina Margherita' Hospital, Rome, Italy., Garufi C; Division of Medical Oncology, Pescara Hospital, Pescara, Italy., Barni S; Department of Oncology, Oncology Unit, ASST Bergamo Ovest, Treviglio, Italy., Mirabelli R; Department of Hematology & Oncology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy., Sarmiento R; Oncology Unit, San Filippo Neri Hospital, Rome, Italy., Veltri EM; Oncology Unit, S. Maria Goretti Hospital, Latina, Italy., D'Auria G; Medical Oncology, Sandro Pertini Hospital, Rome, Italy., Paris I; Gynecology Oncology Unit, Catholic University of the Sacred Heart, Rome, Italy., Giotta F; Department of Medical Oncology, 'Giovanni PaoloII' Institute, Bari, Italy., Lorusso V; Department of Medical Oncology, 'Giovanni PaoloII' Institute, Bari, Italy., Cardillo F; Oncology Unit, Formia Hospital, ASL Latina, Italy., Landucci E; UO Oncologia Medica I, S. Chiara Hospital, Dipartimentodi Oncologia, Dei Trapianti e Delle Nuove Tecnologie, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy., Mauri M; Division of Oncology, San Giovanni Hospital, Rome, Italy., Ficorella C; Medical Oncology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy., Roselli M; Department of Systems Medicine, Medical Oncology, University of Rome 'Tor Vergata', Rome, Italy., Adamo V; Medical Oncology Unit A.O. Papardo & Department Human Pathology University of Messina., Ricciardi GRR; Medical Oncology Unit A.O. Papardo & Department Human Pathology University of Messina., Russo A; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy., Berardi R; Oncology Clinic, Università Politecnica delle Marche, Ospedali Riuniti di Ancona, Ancona, Italy., Pistelli M; Oncology Clinic, Università Politecnica delle Marche, Ospedali Riuniti di Ancona, Ancona, Italy., Fiorio E; U.O.C. Oncology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy., Cannita K; Medical Oncology, St. Salvatore Hospital, L'Aquila, Italy., Sini V; Oncology Unit, ASL Roma 1, Santo Spirito Hospital, Rome, Italy., D'Ostilio N; U.O.C. Lanciano-Vasto, Italy., Foglietta J; Medical Oncology, P.O. Narni-Amelia, Terni, Italy., Greco F; Department of Pathology, Surgery and Oncology, 'Mater Salutis' Hospital, ULSS21, Verona, Italy., Zamagni C; Medical Oncology Unit, Addarii Institute of Oncology, S. Orsola-Malpighi Hospital, Bologna, Italy., Garrone O; Medical Oncology, A.O. Ospedale di Insegnamento S. Crocee Carle, Cuneo, Italy., Di Cocco B; Oncology Unit, S. Maria Goretti Hospital, Latina, Italy., Baldini E; Department of Oncology, Lucca Hospital, Lucca, Italy., Livi L; Radiation Oncology Unit and Department of Clinical and Experimental Biomedical Sciences 'Mario Serio', Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy., Desideri I; Radiation Oncology Unit and Department of Clinical and Experimental Biomedical Sciences 'Mario Serio', Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy., Meattini I; Radiation Oncology Unit and Department of Clinical and Experimental Biomedical Sciences 'Mario Serio', Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy., Sarobba G; Department of Medical Oncology, ASL Nuoro, Nuoro, Italy., Del Medico P; Division of Medical Oncology, Reggio Calabria General Hospital, Reggio Calabria, Italy., De Tursi M; Department of Medical, Oral and Biotechnological Sciences, Centro Scienze dell'Invecchiamento e Medicina Traslazionale -CeSI-MeT, Chieti, Italy., Generali D; Breast Cancer Unit & Translational Research Unit, ASST Cremona, Cremona, Italy., De Maria R; Department of Medical Oncology, Policlinico Universitario 'A. Gemelli', Rome, Italy.; Universita Cattolica del Sacro Cuore, Roma., Risi E; Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Prato, Italy., Ciliberto G; Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Sperduti I; Bio-Statistics Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Villa A; Department of Medical Oncology, Policlinico Universitario 'A. Gemelli', Rome, Italy.; Universita Cattolica del Sacro Cuore, Roma., Barba M; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Di Leo A; Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Prato, Italy., Vici P; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Publikováno v: International journal of cancer [Int J Cancer] 2020 Apr 01; Vol. 146 (7), pp. 1917-1929. Date of Electronic Publication: 2019 Aug 07.

A three-week schedule of gemcitabine-cisplatin in advanced non-small cell lung cancer with two different cisplatin dose levels: a phase II randomised trial

Autor: Rinaldi, M, Crinò, L, Scagliotti, Giorgio Vittorio, Mosconi, Am, Demarinis, F, Gridelli, C, Selvaggi, G, DELLA GIULIA, M, Darwish, S, Porrozzi, S, Novello, Silvia, Cipri, A, Bartolucci, R, Calandri, C, Tonato, M.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______970::2c6093c5713da433d0a4f2a1df68be7d
http://hdl.handle.net/2318/79614

Neurological Complications in Children With Cancer: Experience From a Single Center in Türkiye.

Autor: Kara, Leyla¹, Unal, Ekrem², Per, Huseyin³, Kumandas, Sefer³, Canpolat, Mehmet³, Elmali, Ferhan⁴, Ozcan, Alper², Yilmaz, Ebru², Karakukcu, Musa³, Ozdemir, Mehmet Akif², Patiroglu, Turkan², Gumus, Hakan³ hakgumus@erciyes.edu.tr

Publikováno v: Journal of Clinical Practice & Research. Mar2024, Vol. 46 Issue 2, p154-160. 7p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Future Perspectives in the Second Line Therapeutic Setting for Non-Oncogene Addicted Non-Small-Cell Lung Cancer.

Autor: Siringo, Marco^1,2 (AUTHOR) marco.siringo@uniroma1.it, Baena, Javier^1,3 (AUTHOR) javier.baena@salud.madrid.org, Bote de Cabo, Helena^1,3 (AUTHOR) helenabdc@usal.es, Torres-Jiménez, Javier^1,3 (AUTHOR) javier.torres@salud.madrid.org, Zurera, María^1,3 (AUTHOR) mzureberj@gmail.com, Zugazagoitia, Jon^1,3,4 (AUTHOR) j.zugazagoitia.imas12@h12o.es, Paz-Ares, Luis^1,3,4,5 (AUTHOR) j.zugazagoitia.imas12@h12o.es

Publikováno v: Cancers. Dec2023, Vol. 15 Issue 23, p5505. 22p.